scispace - formally typeset
M

Murat Inanc

Researcher at Istanbul University

Publications -  157
Citations -  4970

Murat Inanc is an academic researcher from Istanbul University. The author has contributed to research in topics: Antiphospholipid syndrome & Lupus erythematosus. The author has an hindex of 35, co-authored 156 publications receiving 4103 citations.

Papers
More filters
Journal ArticleDOI

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

Jérôme Avouac, +127 more
TL;DR: A core set of preliminary items considered as important for the very early diagnosis of systemic sclerosis were identified in a Delphi exercise among 110 experts in the field of SSc.
Journal ArticleDOI

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in behçet's disease: An open-label trial

TL;DR: The results of this trial suggest that infliximab is effective in suppressing the occurrence of uveitis attacks, has a corticosteroid-sparing effect, and has favorable implications for the visual prognosis of patients with resistant Behçet's Uveitis.
Journal ArticleDOI

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.

TL;DR: It is indicated that a significant proportion of patients initially presenting with ITP and APA positivity developed APS, and the persistent presence of APAs is an important risk factor for the development of APS.
Journal ArticleDOI

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

TL;DR: Seizures occurred close to SLE diagnosis, in patients with African race/ethnicity, lower educational status and cumulative organ damage, and there was an association with disease activity but not with autoantibodies.